GB1451669A
(en)
*
|
1974-01-02 |
1976-10-06 |
Radiochemical Centre Ltd |
Protein staining
|
JPS5112922A
(en)
*
|
1974-07-19 |
1976-01-31 |
Eiken Chemical |
Kasuitaihorumonno sokuteihoho
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
JPS52108017A
(en)
*
|
1976-03-04 |
1977-09-10 |
Eiken Chemical |
Measurement for thyroid gland hormon
|
JPS5341420A
(en)
*
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
JPS5386013A
(en)
*
|
1976-11-24 |
1978-07-29 |
Ajinomoto Co Inc |
Quantitative analysis of pituitary hormone
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
US4197287A
(en)
*
|
1977-06-10 |
1980-04-08 |
Ventrex Laboratories Inc. |
Method and apparatus for performing in nitro clinical diagnostic tests using a solid phase assay system having special utility for use with automatic pipetting equipment
|
US4235960A
(en)
*
|
1977-07-29 |
1980-11-25 |
The Medical College Of Wisconsin, Inc. |
Competitive enzyme-linked immunoassay
|
CA1108516A
(fr)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Methode pour detecter les traces d'antibiotiques
|
US4231750A
(en)
*
|
1977-12-13 |
1980-11-04 |
Diagnostic Reagents, Inc. |
Methods for performing chemical assays using fluorescence and photon counting
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
US4376165A
(en)
*
|
1978-06-22 |
1983-03-08 |
Miles Laboratories, Inc. |
Method of preparing an enzyme-labeled ligand for use in specific binding assays and the labeled conjugate produced thereby
|
US4238565A
(en)
*
|
1978-06-22 |
1980-12-09 |
Miles Laboratories, Inc. |
Specific binding assay with a prosthetic group as a label component
|
FR2432713A1
(fr)
*
|
1978-08-02 |
1980-02-29 |
Inst Nat Sante Rech Med |
Application de la d5,3-ceto steroide isomerase dans les dosages immunoenzymatiques
|
JPS5545546A
(en)
*
|
1978-09-25 |
1980-03-31 |
Kanemitsu Doukou Yousetsushiyo:Goushi |
Production of sheet metal pulley
|
JPS5561329A
(en)
*
|
1978-10-27 |
1980-05-09 |
Toupure Kk |
Bulge forming method
|
JPS5575822A
(en)
*
|
1978-12-05 |
1980-06-07 |
Niigataken |
Hydraulic bulging method for metallic container
|
US4278653A
(en)
*
|
1979-02-01 |
1981-07-14 |
New England Nuclear Corporation |
Methods and kits for double antibody immunoassay providing a colored pellet for easy visualization
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4318982A
(en)
*
|
1979-06-04 |
1982-03-09 |
Miles Laboratories, Inc. |
FMN-Labeled specific binding assay
|
US4318983A
(en)
*
|
1979-06-04 |
1982-03-09 |
Miles Laboratories, Inc. |
Fad-labeled specific binding assay monitored with apoglutathione reductase or apolipoamide dehydrogenase
|
US4340668A
(en)
*
|
1979-06-04 |
1982-07-20 |
Miles Laboratories, Inc. |
Heme-labeled specific binding assay
|
JPS55162059A
(en)
*
|
1979-06-05 |
1980-12-17 |
Mochida Pharmaceut Co Ltd |
Measuring method for antigen, antibody or their complex and measurement reagent kit
|
FR2459479B1
(fr)
*
|
1979-06-21 |
1983-07-08 |
Inst Nat Sante Rech Med |
Procede de separation d'une substance proteinique a partir d'une solution la contenant par filtration d'affinite et application dudit procede aux dosages enzymatiques
|
JPS564324A
(en)
*
|
1979-06-22 |
1981-01-17 |
Toupure Kk |
Bulging method
|
US4378344A
(en)
*
|
1979-09-28 |
1983-03-29 |
Ventrex Laboratories, Inc. |
Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4410634A
(en)
*
|
1979-10-26 |
1983-10-18 |
Dynasciences Corporation |
Method of passively adsorbing immuno-reactive haptens to solid phases
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
EP0079962B1
(fr)
*
|
1981-06-02 |
1985-08-28 |
Electro-Nucleonics, Inc. |
Analyse par immuno precipitation
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
US4350659A
(en)
*
|
1981-07-30 |
1982-09-21 |
Corning Glass Works |
Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4861705A
(en)
*
|
1983-01-31 |
1989-08-29 |
Yeda Research And Development Company, Ltd. |
Method for removing components of biological fluids
|
US4778752A
(en)
*
|
1983-10-11 |
1988-10-18 |
Scripps Clinic And Research Foundation |
Receptors specific for hapten-modified self proteins
|
US4727022A
(en)
*
|
1984-03-14 |
1988-02-23 |
Syntex (U.S.A.) Inc. |
Methods for modulating ligand-receptor interactions and their application
|
DE3430905A1
(de)
*
|
1984-08-22 |
1986-02-27 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur bestimmung einer immunologisch bindefaehigen substanz
|
US4760142A
(en)
*
|
1984-11-27 |
1988-07-26 |
Hoechst Celanese Corporation |
Divalent hapten derivatives
|
CH670709A5
(fr)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US4868132A
(en)
*
|
1987-02-03 |
1989-09-19 |
Abbott Laboratories |
Fluorescence polarization immunoassay for amphetamine/methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
JPH0833394B2
(ja)
*
|
1990-10-03 |
1996-03-29 |
三洋化成工業株式会社 |
酵素標識ハプテンの製法
|
JPH06506688A
(ja)
*
|
1991-04-10 |
1994-07-28 |
バイオサイト・ダイアグノスティックス・インコーポレイテッド |
クロストークインヒビターおよびその使用
|
US6777190B1
(en)
|
1991-04-10 |
2004-08-17 |
Biosite, Inc. |
Crosstalk inhibitors and their uses
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5484709A
(en)
*
|
1993-09-10 |
1996-01-16 |
Ensys, Inc. |
Immunoassay method for detecting an immunologically non-remarkable compound, its components and a kit for use in performing the same
|
WO1995034640A1
(fr)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
Neuronatine, nouveau gene neuronal neonatal
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
AU9110798A
(en)
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
CA2307345A1
(fr)
|
1997-10-17 |
1999-04-29 |
University Of South Florida |
Procede de diagnostic et de surveillance des deficiences immunitaires cellulaires
|
WO2000018885A1
(fr)
*
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(fr)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation de la voie de phospholipase a2 utilisee comme procede therapeutique
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
NZ513303A
(en)
*
|
1999-02-04 |
2003-03-28 |
Technion Res & Dev Foundation |
Three dimensional plug flow bioreactor, and its use for the maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
WO2001036586A2
(fr)
*
|
1999-11-19 |
2001-05-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Gene et proteine de beta-glucosidase d'aspergillus niger et leurs utilisations
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
PT2078531E
(pt)
|
2000-08-08 |
2012-08-06 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para modular a angiogénese
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
EP1379127B1
(fr)
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
EP2186530B1
(fr)
|
2000-11-17 |
2013-05-22 |
Vascular Biogenics Ltd. |
Promoteurs présentant une specificité pour des cellules endotheliales et procédés d'utilisation desdits promoteurs
|
EP1341543A4
(fr)
|
2000-11-24 |
2009-09-02 |
Vascular Biogenics Ltd |
Procedes faisant appels a des phospholipides oxydes definis, ainsi que compositions contenant ces derniers, pour la prevention et le traitement de l'atherosclerose
|
CA2430473A1
(fr)
|
2000-11-30 |
2002-06-06 |
Molecular Skincare Limited |
Diagnostic et traitement de maladie
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
US20040078842A1
(en)
*
|
2001-01-17 |
2004-04-22 |
Aviah Zilberstein |
Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
|
AU2002230061A1
(en)
*
|
2001-01-31 |
2002-08-12 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
AU2002330724A1
(en)
|
2001-08-16 |
2003-03-10 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
EP2277887A3
(fr)
|
2001-10-19 |
2011-02-16 |
Vascular Biogenics Ltd. |
Constructions de polynucléotides, compositions pharmaceutiques et procédés pour la régulation négative ciblée de l'angiogenèse et du traitement contre le cancer.
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(fr)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
EP1485075A4
(fr)
*
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
Ligands de liaison au complexe mhc-peptide
|
WO2003078567A2
(fr)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
|
US7611723B2
(en)
*
|
2002-03-26 |
2009-11-03 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003247143B2
(en)
|
2002-08-01 |
2009-07-16 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
WO2004037204A2
(fr)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
|
EP2295980A1
(fr)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molécules et leurs procédés d'utilisation pour la mesure de fer non lié par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
AU2003286410A1
(en)
|
2002-12-12 |
2004-06-30 |
R.B.T (Rakuto Bio Technologies) Ltd. |
Methods of producing lignin peroxidase and its use in skin and hair lightening
|
CN100549163C
(zh)
|
2002-12-16 |
2009-10-14 |
技术研究及发展基金有限公司 |
制备无饲养细胞、无异源的人胚胎干细胞的方法以及使用该方法制备的干细胞培养物
|
EP1587953B1
(fr)
|
2003-01-02 |
2012-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Methodes de prediction de potentiel a tirer benefice d'un traitement antioxydant pour la prevention de maladies cardiovasculaires chez des patients hyperglycemiques
|
WO2004060791A1
(fr)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Nanostructures de peptides encapsulant une matiere etrangere ainsi que procede de fabrication correspondant
|
WO2004078991A2
(fr)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
CN101942449B
(zh)
|
2003-05-22 |
2014-07-02 |
伊沃基因有限公司 |
提高植物非生物胁迫耐受性和/或生物量的方法及用该方法所产生的植物
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
WO2004111183A2
(fr)
*
|
2003-06-19 |
2004-12-23 |
Evogene Ltd. |
Sequences nucleotidiques pour reguler l'expression genetique chez des trichromes vegetaux, et genes hybrides et procedes dans lesquels elles interviennent
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
JP5137400B2
(ja)
*
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
AU2004267383A1
(en)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Bacterial strains, compositions including same and probiotic use thereof
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
PT1678209E
(pt)
|
2003-10-07 |
2011-06-30 |
Yeda Res & Dev |
Anticorpos para a nik, a sua preparação e a sua utilização
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
WO2005040359A1
(fr)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccin contre les parodontopathies
|
JP5039383B2
(ja)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
WO2005061018A1
(fr)
|
2003-12-22 |
2005-07-07 |
Regentis Biomaterials Ltd. |
Matrice comprenant un squelette proteique reticule naturel
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
EP3006039B1
(fr)
|
2004-03-02 |
2021-01-06 |
Acceleron Pharma Inc. |
Alk7 polypeptides pour stimuler la perte de graisse
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
EP1766058A4
(fr)
*
|
2004-06-14 |
2008-05-21 |
Evogene Ltd |
Polynucléotides et polypeptides impliqués dans le développement de la fibre végétale et procédés permettant de les utiliser
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(fr)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Utilisation d'agents anti-amyloides pour traiter et determiner des infections pathogenes
|
EP1799812A4
(fr)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
MX2007003767A
(es)
|
2004-09-29 |
2007-07-17 |
Collplant Ltd |
Colageno recombinante producido en planta.
|
CA2582041C
(fr)
*
|
2004-09-29 |
2015-08-04 |
Levava Roiz |
Rnase t2 humaine recombinee et utilisations associees
|
EP1809374A4
(fr)
*
|
2004-10-12 |
2008-09-10 |
Closed Loop Therapies Ltd |
Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1844403A4
(fr)
*
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
Communication iconique
|
US20080082678A1
(en)
*
|
2005-01-16 |
2008-04-03 |
Zlango Ltd. |
Communications Network System and Methods for Using Same
|
WO2007080558A2
(fr)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Systeme de reseau de communication et ses procedes d'utilisation
|
EP1843850B1
(fr)
|
2005-01-31 |
2015-11-18 |
Realbio Technologies Ltd. |
Dispositif capillaire a flux lateral de reaction par etapes multiples
|
WO2006087722A1
(fr)
|
2005-02-17 |
2006-08-24 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates pour le traitement de l'endometriose
|
JP5432455B2
(ja)
|
2005-02-25 |
2014-03-05 |
ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、(エー.アール.オー.)、ボルカニ センター |
炎症治療用の果実細胞培養抽出物
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1874334A4
(fr)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
JP2008546385A
(ja)
|
2005-06-16 |
2008-12-25 |
ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド |
Cns疾患を治療するための単離された細胞および単離された細胞を含む集団
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
WO2007007317A1
(fr)
|
2005-07-07 |
2007-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Agents de type acide nucleique pour la regulation a la baisse de h19 et methodes d'emploi desdits agents
|
EP2487182B1
(fr)
|
2005-07-07 |
2019-10-23 |
FULCRUM SP Ltd. |
Polypeptides sp1, polypeptides sp1 modifiés et leurs utilisations
|
EP2441840B1
(fr)
|
2005-07-18 |
2017-09-06 |
Protalix Ltd. |
Administration mucosale ou enterale de macromolecules biologiquement actives
|
JP5017269B2
(ja)
|
2005-07-26 |
2012-09-05 |
ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ |
結核状態に特有の抗体プロフィール
|
EP1945257A4
(fr)
*
|
2005-08-08 |
2009-05-06 |
Onconon Llc |
Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
|
EP1928479B1
(fr)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
|
EP1962719A4
(fr)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Milieux de culture de cellules souches
|
EP1926814B1
(fr)
|
2005-09-22 |
2010-04-28 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Constructions d acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP2716654A1
(fr)
|
2005-10-24 |
2014-04-09 |
Evogene Ltd. |
Polypeptides isolés, polynucléotides codant pour ces derniers, plantes transgéniques exprimant ces derniers et méthodes utilisant ces derniers
|
EP2390312A1
(fr)
|
2005-11-29 |
2011-11-30 |
Gamida Cell Ltd. |
Méthodes d'amélioration de prise de greffe et de nostocytose de cellules souches
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP1977312A2
(fr)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Communication iconique
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US20090197286A1
(en)
|
2006-02-06 |
2009-08-06 |
Rappaport Family Institute For Research In The Med |
Methods and Kit for Diagnosing T1DM
|
EP1991852B1
(fr)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Procédés pour identifier un phénotype cellulaire
|
SG170761A1
(en)
|
2006-03-23 |
2011-05-30 |
Pluristem Ltd |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(fr)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
CN101448951B
(zh)
*
|
2006-05-19 |
2013-04-10 |
泰华制药工业有限公司 |
融合蛋白、其用途以及制备方法
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US8629259B2
(en)
|
2006-07-20 |
2014-01-14 |
Yeda Research And Development Co. Ltd. |
Photosynthetic organisms and compositions and methods of generating same
|
EP2064319B1
(fr)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
|
JP2010502729A
(ja)
*
|
2006-09-08 |
2010-01-28 |
ウィスコンシン アルムニ リサーチ ファウンデーション |
ヨーネ菌に対する抗体用アッセイ
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
US20100129656A1
(en)
|
2006-10-05 |
2010-05-27 |
Technion Research & Develpment Foundation Ltd |
Microtubes and methods of producing same
|
US20080131954A1
(en)
*
|
2006-11-30 |
2008-06-05 |
Canon U.S. Life Sciences, Inc. |
Method of Separating Target DNA from Mixed DNA
|
EP2383345B1
(fr)
|
2006-12-20 |
2017-11-22 |
Evogene Ltd. |
Polynucléotides et polypeptides impliqués dans le développement de fibres végétales et procédés d'utilisation
|
US7928083B2
(en)
*
|
2007-01-16 |
2011-04-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
EP2117616A2
(fr)
|
2007-01-31 |
2009-11-18 |
Technion Research & Development Foundation Ltd. |
Échafaudages électrofilés et leurs procédés de génération et d'utilisation
|
EP2125050B1
(fr)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
|
EP2839839B1
(fr)
|
2007-02-28 |
2018-01-17 |
Yeda Research And Development Company Limited |
Sequences de ciblage du noyau
|
AU2008234530B2
(en)
|
2007-03-29 |
2013-03-28 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
WO2008120216A1
(fr)
|
2007-04-02 |
2008-10-09 |
Ramot At Tel Aviv University Ltd. |
Procédés permettant de détecter des cellules cancéreuses et leur utilisation pour diagnostiquer et surveiller le traitement de la maladie
|
MX2009010858A
(es)
|
2007-04-09 |
2009-11-02 |
Evogene Ltd |
Polinucleotidos, polipeptidos y metodos para aumentar el contenido de aceite, la velocidad de crecimiento y biomasa de las plantas.
|
WO2014064687A1
(fr)
|
2012-10-22 |
2014-05-01 |
Deliversir Ltd |
Système d'administration d'agents thérapeutiques dans des cellules vivantes et des noyaux cellulaires
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
PL2144633T4
(pl)
*
|
2007-04-23 |
2015-02-27 |
Sabag Rfa Ltd |
Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
ES2564312T3
(es)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Métodos y kits para detectar células fetales en la sangre materna
|
CA2685954A1
(fr)
|
2007-05-03 |
2008-11-13 |
Agency For Science, Technology And Research |
Fixation d'anticorps sur un polypeptide prl-1 ou prl-3 intracellulaire
|
EP3366762B1
(fr)
|
2007-05-07 |
2020-07-08 |
Protalix Ltd. |
Bioréacteur jetable à grande échelle
|
EP2176409B1
(fr)
|
2007-07-11 |
2012-01-04 |
Yeda Research And Development Co. Ltd. |
Systèmes de produits de construction d'acide nucléique pouvant diagnostiquer ou traiter un état cellulaire
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009010968A2
(fr)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
|
CN102037127A
(zh)
|
2007-07-24 |
2011-04-27 |
伊沃基因有限公司 |
多核苷酸及其编码的多肽和用于在表达所述多核苷酸、多肽的植物中用所述多核苷酸、多肽提高非生物胁迫耐受性和/或生物量和/或产量的方法
|
JP5659014B2
(ja)
|
2007-08-02 |
2015-01-28 |
ジリード バイオロジクス,インク. |
線維症、腫瘍浸潤、血管新生及び転移の治療及び診断のための方法及び組成物
|
WO2009022328A2
(fr)
|
2007-08-15 |
2009-02-19 |
Yeda Research And Development Co. Ltd. |
Régulateurs de la mmp-9 et leurs utilisations
|
AU2008299318A1
(en)
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
WO2009037690A1
(fr)
|
2007-09-19 |
2009-03-26 |
Pluristem Ltd. |
Cellules adhérentes provenant de tissus adipeux ou placentaires et leur utilisation thérapeutique
|
CA2702655A1
(fr)
|
2007-10-19 |
2009-04-23 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprenant des semaphorines pour le traitement de maladies associees a l'angiogenese et leurs procedes de selection
|
JP2011504374A
(ja)
|
2007-11-26 |
2011-02-10 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド |
繊維状ポリペプチドおよび多糖を含む組成物
|
AU2008344935C1
(en)
|
2007-12-27 |
2016-07-14 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
EP2245055A2
(fr)
*
|
2008-01-31 |
2010-11-03 |
Compugen Ltd. |
Polypeptides et polynucléotides et leurs utilisations en tant que cible médicamenteuse pour produire des médicaments et des produits biologiques
|
US9297094B2
(en)
|
2008-02-21 |
2016-03-29 |
Technion Research & Development Foundation Ltd. |
Use of electrospun microtubes for drug delivery
|
WO2009117462A1
(fr)
*
|
2008-03-18 |
2009-09-24 |
Wisconsin Alumini Research Foundation |
Test de criblage de culture mycobactérienne pour une bactérie complexe de mycobacterium avium
|
WO2009125394A1
(fr)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anticorps anti-immunodéficience humaine et leurs utilisations
|
US9132587B2
(en)
*
|
2008-04-10 |
2015-09-15 |
Stratasys Ltd. |
System and method for three dimensional model printing
|
CA2721507C
(fr)
|
2008-04-18 |
2017-10-03 |
Collplant Ltd. |
Procedes de generation et d'utilisation de procollagene
|
EP2268129B1
(fr)
|
2008-04-21 |
2015-06-17 |
Danziger Innovations Ltd. |
Vecteurs d'expression de virus végétaux et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
|
SG176464A1
(en)
|
2008-05-09 |
2011-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
CA3148194A1
(fr)
*
|
2008-05-22 |
2009-11-26 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement vegetal, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique des plantes et l'efficacite d'utilisation de l'azote
|
CA2725637A1
(fr)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Procedes de traitement de maladies inflammatoires du colon
|
WO2009144718A1
(fr)
|
2008-05-28 |
2009-12-03 |
Ramot At Tel Aviv University Ltd. |
Cellules souches mésenchymateuses destinées au traitement de troubles du snc
|
CN102076415B
(zh)
|
2008-06-29 |
2015-06-24 |
瑞尔比奥技术有限公司 |
尤其可用作生物测定过程中的捕捉装置的液体转移装置
|
EP2320953B1
(fr)
|
2008-08-08 |
2015-07-15 |
Genisphere, LLC |
Dendrimères d'adn à longue durée d'action et méthodes afférentes
|
WO2010016806A1
(fr)
|
2008-08-08 |
2010-02-11 |
Agency For Science, Technology And Research (A*Star) |
Vhz pour le diagnostic et le traitement de cancers
|
BR122021014172B1
(pt)
|
2008-08-18 |
2022-09-06 |
Evogene Ltd |
Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, taxa de crescimento, vigor, biomassa e/ou tolerância ao estresse de falta de nitrogênio de uma planta
|
SG190659A1
(en)
|
2008-09-02 |
2013-06-28 |
Pluristem Ltd |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(fr)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions et procédés destinés à traiter une infection par s. pneumoniae
|
CN102186970A
(zh)
|
2008-09-12 |
2011-09-14 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
US9029318B2
(en)
|
2008-09-24 |
2015-05-12 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
EP2347014B1
(fr)
|
2008-10-30 |
2016-09-21 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés et procédés pour les utiliser pour augmenter le rendement, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique de plantes et l'efficacité d'utilisation de l'azote
|
WO2010055525A1
(fr)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Procédé pour prédire la réactivité d'un patient à une thérapie par antifolate
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP2633854B1
(fr)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* pour l'uilisation dans le traitement de la SLA
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
EP2808402A3
(fr)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par interférons
|
MX350550B
(es)
|
2008-12-29 |
2017-09-08 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para aumentar la tolerancia al estres, abiotico, biomasa y/o rendimiento en plantas que los expresan.
|
DK2376528T3
(en)
|
2008-12-29 |
2015-01-05 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
PEPTIDES AND COMPOSITIONS FOR PREVENTING cell adhesion, and methods of use thereof
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
EP2391377A2
(fr)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, compositions pharmaceutiques en contenant et leurs utilisations
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
EP2401362B1
(fr)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
|
EP3862433A3
(fr)
|
2009-03-02 |
2021-11-17 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés, et procédés d'utilisation de ceux-ci pour augmenter un rendement végétal et/ou des caractéristiques agricoles
|
US8546330B2
(en)
|
2009-03-09 |
2013-10-01 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for treatment of neurodegenerative diseases
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
EP2414542B1
(fr)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
|
JP2012522762A
(ja)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
ケラチノサイトの増殖および分化を調節する方法
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
RU2598710C2
(ru)
|
2009-04-30 |
2016-09-27 |
Тел Хашомер Медикал Рисерч Инфрастракче Энд Сервисиз Лтд. |
Антитела к сеасам1 и способы их использования
|
EP2433136B1
(fr)
|
2009-05-19 |
2015-08-26 |
Zetiq Technologies Ltd. |
Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
EP2435072A2
(fr)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Inhibiteurs des protéasomes et leurs utilisations
|
WO2010137021A2
(fr)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de génération de tissu conjonctif
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
MX363447B
(es)
|
2009-06-10 |
2019-03-22 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para mejorar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
|
EP2446267A1
(fr)
|
2009-06-24 |
2012-05-02 |
Health Corporation - Rambam |
Méthodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
CA2768725A1
(fr)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methode de diagnostic du cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
US20120148546A1
(en)
|
2009-08-17 |
2012-06-14 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
CA2770276A1
(fr)
|
2009-08-21 |
2012-02-24 |
Beeologics, Inc. |
Prevention et traitement de maladies des insectes benefiques par l'intermediaire de molecules transcrites vegetales
|
WO2011022670A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
Essais de criblage in vivo
|
KR20120054077A
(ko)
*
|
2009-08-21 |
2012-05-29 |
길리아드 바이오로직스, 인크. |
폐 섬유증 장애의 치료를 위한 방법 및 조성물
|
SG2014004816A
(en)
*
|
2009-08-21 |
2014-03-28 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
MX2012002271A
(es)
*
|
2009-08-21 |
2012-07-20 |
Gilead Biologics Inc |
Metodos y composiciones terapeuticas.
|
JP2013502228A
(ja)
*
|
2009-08-21 |
2013-01-24 |
ギリアド バイオロジクス,インク. |
invitroスクリーニングアッセイ
|
CN106619515A
(zh)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
WO2011030332A2
(fr)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Procédés pour la mobilisation de précurseur hématopoïétique
|
WO2011030336A1
(fr)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
WO2011030329A1
(fr)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode de traitement de tumeurs
|
EP2478009B1
(fr)
|
2009-09-17 |
2016-06-01 |
Ramot at Tel-Aviv University Ltd. |
Peptides pour le traitement de troubles liés au stress oxydatif
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
EP2488646B1
(fr)
|
2009-10-14 |
2017-12-06 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions pour lutter contre les acariens varroa chez l'abeille
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
WO2011048600A1
(fr)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058558A2
(fr)
|
2009-11-12 |
2011-05-19 |
Technion Research & Development Foundation Ltd. |
Milieu de culture, cultures de cellules et procédés de culture de cellules souches pluripotentes dans un état indifférencié
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
EP2504472A1
(fr)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Procédé de production de fibres de collagène
|
CN102639692B
(zh)
|
2009-11-30 |
2015-02-04 |
普拉里斯坦有限公司 |
来源于胎盘的贴壁细胞及其在疾病治疗中的应用
|
WO2011067745A2
(fr)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
WO2011080674A2
(fr)
|
2009-12-28 |
2011-07-07 |
Evogene Ltd. |
Polynucléotides isolés et polypeptides et procédés pour les utiliser afin d'augmenter le rendement des cultures, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique des plantes et l'efficacité d'utilisation de l'azote
|
CN107254439B
(zh)
|
2009-12-29 |
2022-01-11 |
加米达细胞有限公司 |
增强自然杀伤细胞增殖和活性的方法
|
EP3159405B8
(fr)
|
2010-01-05 |
2018-11-07 |
Vascular Biogenics Ltd. |
Procédés pour l'utilisation d'un agent adénoviral antiangiogenèse spécifique
|
SG182490A1
(en)
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
CN102822202B
(zh)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
抑制金属蛋白的抗体
|
US8680246B2
(en)
|
2010-02-04 |
2014-03-25 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(fr)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Méthodes d'inhibition de la nécrose
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
EP2545176B1
(fr)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
US9121022B2
(en)
|
2010-03-08 |
2015-09-01 |
Monsanto Technology Llc |
Method for controlling herbicide-resistant plants
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
EP2556085A2
(fr)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
EP2557913B1
(fr)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
AU2011243958B2
(en)
|
2010-04-18 |
2015-01-22 |
Yeda Research And Development Co. Ltd. |
Molecules and methods of using same for treating ErbB/ErbB ligands associated diseases
|
BR122021002340B1
(pt)
|
2010-04-28 |
2022-04-05 |
Evogene Ltd |
Método de aumento de biomassa, taxa de crescimento e/ou eficiência de uso de nitrogênio de uma planta
|
WO2011138778A2
(fr)
|
2010-05-04 |
2011-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés permettant d'identifier des inhibiteurs de polypeptides d'intérêt
|
WO2011138785A2
(fr)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Utilisation thérapeutique de ccl1
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
PL2569417T3
(pl)
|
2010-05-13 |
2018-12-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania
|
WO2011151833A1
(fr)
|
2010-06-03 |
2011-12-08 |
Ramot At Tel-Aviv University Ltd. |
Méthodes de traitement du diabète et compositions capables de traiter le diabète
|
KR20130123357A
(ko)
|
2010-06-07 |
2013-11-12 |
오스나트 에슈어-파비안 |
저산소증과 관련된 질환의 진단방법 및 키트
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
US9512188B2
(en)
|
2010-07-12 |
2016-12-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
US20130189284A1
(en)
|
2010-07-15 |
2013-07-25 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
BR112013000984A2
(pt)
|
2010-07-15 |
2017-10-03 |
Technion Res & Dev Foundation |
Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014208A2
(fr)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Procédés et systèmes d'estimation de la clonalité de cultures cellulaires
|
WO2012014207A2
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Procédé de génération de cellules souches pluripotentes induites à partir de kératinocytes dérivés de follicules pileux prélevés
|
WO2012014205A1
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
|
WO2012017439A2
(fr)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
|
US9394523B2
(en)
|
2010-08-22 |
2016-07-19 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
AU2011298034B2
(en)
|
2010-08-30 |
2016-05-26 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
WO2012032520A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
SG10202109393RA
(en)
|
2010-09-07 |
2021-10-28 |
Technion Res & Dev Foundation |
Novel Methods And Culture Media For Culturing Pluripotent Stem Cells
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
SG188471A1
(en)
|
2010-09-08 |
2013-04-30 |
Yeda Res & Dev |
An immunosuppressive drug combination for a stable and long term engraftment
|
HUE031063T2
(en)
|
2010-09-08 |
2017-06-28 |
Yeda Res & Dev |
Anti-third party use of central memory T cells for leukemia / anti-lymphoma treatment
|
EP2616539A1
(fr)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Procédés d'expansion et de redifférenciation de cellules bêta des îlots
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
WO2012052872A2
(fr)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
WO2012056452A2
(fr)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
|
CN103370337B
(zh)
|
2010-10-28 |
2015-12-09 |
耶达研究及发展有限公司 |
用于产生针对金属酶的抗体的方法
|
CA2815927A1
(fr)
|
2010-11-03 |
2012-05-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. |
Plantes transgeniques a rendements de saccharification ameliores, et procede pour les generer
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
AR083885A1
(es)
|
2010-11-15 |
2013-03-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides
|
EP2640404B1
(fr)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
EP2463382A1
(fr)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Procédé d'identification de E. Coli M-17
|
EP2652125B1
(fr)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
AR084511A1
(es)
|
2010-12-22 |
2013-05-22 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la tolerancia al estres abiotico, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o eficacia en el uso de nitrogeno de las plantas
|
RU2013135305A
(ru)
|
2010-12-28 |
2015-02-10 |
Камедис Лтд. |
Растительные экстракты для лечения и профилактики инфекций
|
SI3272861T1
(sl)
|
2011-01-20 |
2020-06-30 |
Protalix Ltd. |
Alfa-galaktozidazni sestavki
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
WO2012114339A1
(fr)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
|
CN103597078B
(zh)
|
2011-03-02 |
2016-12-14 |
富途锐基尼以色列有限公司 |
具有功能失调的t3ss蛋白的抗菌性转基因植物
|
WO2012117373A1
(fr)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
AU2012226398B9
(en)
|
2011-03-06 |
2017-04-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
WO2012120518A1
(fr)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions et méthodes de diagnostic et de traitement de phénylcétonurie (pcu)
|
EP2685976B1
(fr)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Analogues de quinolone pour le traitement de maladies auto-immunes
|
AU2012227883A1
(en)
|
2011-03-17 |
2013-10-24 |
Ramot At Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
WO2012127320A1
(fr)
|
2011-03-22 |
2012-09-27 |
Pluristem Ltd. |
Procédés de traitement de blessures dues aux expositions aux irradiations ou aux produits chimiques
|
JP5960793B2
(ja)
|
2011-03-24 |
2016-08-02 |
ニューリム ファーマシューティカルズ(1991)リミテッド |
神経保護ペプチド
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
US8728758B2
(en)
|
2011-04-06 |
2014-05-20 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
CN103476924A
(zh)
|
2011-04-15 |
2013-12-25 |
普拉里斯坦有限公司 |
收获细胞的方法和系统
|
WO2012150598A2
(fr)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés et leurs procédés d'utilisation pour augmenter le rendement de plantes, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique de plantes et l'efficacité d'utilisation de l'azote
|
EP2704793B1
(fr)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
EP3263127B1
(fr)
|
2011-05-23 |
2019-08-21 |
Yeda Research and Development Co. Ltd |
Utilisation de la phosphorylation akt en tant que biomarqueur de pronostic de maladies neurodégénératives et le traitement de ceux-ci
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
CN104039812A
(zh)
|
2011-05-31 |
2014-09-10 |
和黄生物膜医疗解决方案有限公司 |
细胞聚集体的分散和脱离
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(fr)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
|
WO2012176203A1
(fr)
|
2011-06-23 |
2012-12-27 |
Kaiima Bio Agritech Ltd. |
Blé commun, plantes ou parties de celles-ci ayant un génome partiellement ou complètement multiplié, hybrides et produits de ceux-ci, et procédés de génération et d'utilisation
|
US20140143905A1
(en)
|
2011-07-20 |
2014-05-22 |
Amit Avidov |
Maize plants having a partially or fully multiplied genome and uses thereof
|
EP2550982A1
(fr)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Dispositifs pour applications chirurgicales
|
ES2632212T3
(es)
|
2011-08-04 |
2017-09-11 |
Yeda Research And Development Co. Ltd. |
miR-135 y composiciones que lo comprenden para el tratamiento de afecciones médicas asociadas con la serotonina
|
US9499793B2
(en)
|
2011-08-09 |
2016-11-22 |
Yeda Research And Development Co. Ltd. |
Downregulation of miR-7 for promotion of beta cell differentiation and insulin production
|
EP2741602A1
(fr)
|
2011-08-14 |
2014-06-18 |
Kaiima Bio Agritech Ltd. |
Plantes de blé dur ayant un génome partiellement ou complètement multiplié, et leurs utilisations
|
US9959392B2
(en)
|
2011-09-07 |
2018-05-01 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
MX351226B
(es)
|
2011-09-08 |
2017-10-05 |
Yeda Res & Dev |
Celulas t con memoria central anti tercera parte, metodos para producirlas y uso de las mismas en transplante y tratamiento de enfermedades.
|
EP2753716B1
(fr)
|
2011-09-08 |
2017-11-01 |
Yeda Research and Development Co. Ltd. |
Nouveaux biomarqueurs de risque pour le cancer du poumon
|
AU2012308686B2
(en)
|
2011-09-13 |
2018-05-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
AU2012308694B2
(en)
|
2011-09-13 |
2018-06-14 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
AU2012308659B2
(en)
|
2011-09-13 |
2017-05-04 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
UA116090C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
WO2013056377A1
(fr)
|
2011-10-21 |
2013-04-25 |
Augurex Life Sciences Corporation |
Antigènes dérivés de peptides 14-3-3η citrullinés et utilisations de ceux-ci dans le diagnostic de polyarthrite rhumatoïde
|
WO2013061328A2
(fr)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Procédé de traitement du cancer
|
CN103917647B
(zh)
|
2011-11-03 |
2020-07-10 |
夸克制药公司 |
用于神经保护的方法和组合物
|
WO2013070821A1
(fr)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
|
WO2013076729A1
(fr)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Plantes de type otomeria
|
EP2782930B1
(fr)
|
2011-11-27 |
2018-07-11 |
Yeda Research and Development Co. Ltd. |
Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
|
KR20140102730A
(ko)
|
2011-12-08 |
2014-08-22 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
포유류 태아 폐 세포와 이를 치료용으로 사용하는 방법
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
EP2794107B1
(fr)
|
2011-12-22 |
2021-08-11 |
Life Technologies Corporation |
Dispositif capillaire à écoulement latéral séquentiel pour la détermination d'un analyte
|
WO2013093919A2
(fr)
|
2011-12-22 |
2013-06-27 |
Yeda Research And Development Co. Ltd. |
Polythérapie mise en oeuvre pour obtenir une prise de greffe stable et à long terme au moyen de protocoles spécifiques d'appauvrissement des lymphocytes t/b
|
AU2012359984A1
(en)
|
2011-12-28 |
2014-07-10 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
WO2013114371A1
(fr)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Formulation en poudre sèche de dnase i
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
BR112014020119A2
(pt)
|
2012-02-13 |
2020-10-27 |
Gamida-Cell Ltd |
cultura de células-tronco mesenquimais
|
ES2855133T3
(es)
|
2012-02-14 |
2021-09-23 |
Opko Biologics Ltd |
Factores de coagulación de acción prolongada y usos de los mismos
|
IN2014MN01806A
(fr)
|
2012-02-19 |
2015-07-03 |
Protalix Ltd |
|
EP3401394A1
(fr)
|
2012-02-22 |
2018-11-14 |
Exostem Biotec Ltd |
Génération de cellules souches neurales
|
JP6329911B2
(ja)
|
2012-02-22 |
2018-05-23 |
ブレインステム バイオテック リミテッド |
星状膠細胞作製のためのミクロrna
|
US20150101074A1
(en)
|
2012-03-01 |
2015-04-09 |
The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
US9925143B2
(en)
|
2012-04-18 |
2018-03-27 |
Ramot At Tel-Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
ES2627816T3
(es)
|
2012-05-09 |
2017-07-31 |
Yeda Research And Development Co. Ltd. |
Variantes del pro-dominio de tace como inhibidor de TNF-a y su uso médico
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CN104603149B
(zh)
|
2012-05-24 |
2017-06-30 |
万机集团有限公司 |
与预防和治疗狂犬病感染相关的组合物和方法
|
AR091143A1
(es)
|
2012-05-24 |
2015-01-14 |
Seeds Ltd Ab |
Composiciones y metodos para silenciar la expresion genetica
|
WO2013183048A1
(fr)
|
2012-06-03 |
2013-12-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
|
EP2854838B1
(fr)
|
2012-06-04 |
2018-10-17 |
OPKO Biologics Ltd. |
Variants d'oxm pégylés
|
US10023474B2
(en)
|
2012-07-03 |
2018-07-17 |
Nanospun Technologies Ltd. |
Methods for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2880155B1
(fr)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
EP2880151B1
(fr)
|
2012-08-06 |
2020-06-03 |
Brainstorm Cell Therapeutics Ltd. |
Procédés de génération de cellules souches mésechymateuses qui sécrètent des facteurs neurotrophiques
|
US20140068814A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
WO2014041544A1
(fr)
|
2012-09-12 |
2014-03-20 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticules et procédés pour les produire et les utiliser
|
WO2014057490A1
(fr)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
|
WO2014064682A1
(fr)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
CA2891393A1
(fr)
|
2012-11-20 |
2014-05-30 |
Opko Biologics Ltd. |
Procede d'augmentation du volume hydrodynamique de polypeptides par la fixation a des peptides carboxy terminaux de gonadotrophine
|
WO2015079413A2
(fr)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
US20150290233A1
(en)
|
2012-11-29 |
2015-10-15 |
Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
BR112015015975A2
(pt)
|
2013-01-01 |
2018-11-06 |
A. B. Seeds Ltd. |
moléculas de dsrna isoladas e métodos de uso das mesmas para silenciamento das moléculas alvo de interesse.
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
EP3431985A1
(fr)
|
2013-01-17 |
2019-01-23 |
Novellusdx Ltd. |
Procédés et systèmes pour identifier des mutations conductrices spécifiques à un patient
|
WO2014118785A1
(fr)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
|
EP2964669B1
(fr)
|
2013-03-06 |
2018-09-12 |
Protalix Ltd. |
Utilisation de cellules végétales exprimant un inhibiteur du polypeptide tnf alpha en thérapie
|
US20160017020A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
UY35385A
(es)
|
2013-03-13 |
2014-09-30 |
Monsanto Technology Llc |
?métodos y composiciones para el control de malezas?.
|
AU2014249015B2
(en)
|
2013-03-13 |
2020-04-16 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2014147622A1
(fr)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprenant du collagène et prp pour la régénération tissulaire
|
EP2978439B1
(fr)
|
2013-03-24 |
2017-08-16 |
Biokine Therapeutics Ltd. |
Une combinaison d'un antagoniste cxcr4 et cytarabine pour l'utilisation dans le traitement de la leucémie myéloïde
|
CA2909380A1
(fr)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents de regulation a la baisse de l'activite et/ou de la quantite de bcl-xl et/ou bcl-w
|
US10920192B2
(en)
|
2013-04-23 |
2021-02-16 |
Yeda Research And Development Co. Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
CN105555796B
(zh)
|
2013-04-25 |
2019-09-17 |
耶达研究及发展有限公司 |
抑制肽对治疗炎性疾病的用途
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
US10980730B2
(en)
|
2013-05-27 |
2021-04-20 |
Rakuto Bio Technologies Ltd. |
Enzymatic system-containing cosmetic compositions
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
RU2703498C2
(ru)
|
2013-07-19 |
2019-10-17 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с leptinotarsa
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
ES2702674T3
(es)
|
2013-08-29 |
2019-03-04 |
Yeda Res & Dev |
Inhibidores selectivos de la isoforma alfa2 de Na,K-ATPasa y el uso para la reducción de la presión intraocular
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
EP3046929B1
(fr)
|
2013-09-17 |
2019-01-16 |
Yeda Research and Development Co., Ltd. |
Nouveaux peptides d'erk et leurs utilisations
|
WO2015049677A1
(fr)
|
2013-10-01 |
2015-04-09 |
Kadimastem Ltd. |
Différenciation dirigée d'astrocytes à partir de cellules souches pluripotentes humaines pour utilisation dans le criblage de médicaments et le traitement de la sclérose latérale amyotrophique (sla)
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP3060239B1
(fr)
|
2013-10-21 |
2020-05-13 |
OPKO Biologics Ltd. |
Polypeptides à action prolongée et procédés de production et d'administration de ceux-ci
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
AU2014341879B2
(en)
|
2013-11-04 |
2020-07-23 |
Beeologics, Inc. |
Compositions and methods for controlling arthropod parasite and pest infestations
|
EP3074391B1
(fr)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Inhibiteurs de l'arn polymérase i et leurs utilisations
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
AU2015206585A1
(en)
|
2014-01-15 |
2016-07-21 |
Monsanto Technology Llc |
Methods and compositions for weed control using EPSPS polynucleotides
|
WO2015114633A1
(fr)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
|
EP3102192A2
(fr)
|
2014-02-03 |
2016-12-14 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Méthode d'élimination de cellules souches
|
WO2015118537A2
(fr)
|
2014-02-05 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles médicaux associés à la sérotonine, à l'adrénaline, à la noradrénaline, au glutamate et à l'hormone de libération de la corticotropine
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
WO2015118547A1
(fr)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
|
BR112016018489A2
(pt)
|
2014-02-11 |
2017-08-08 |
Brainstorm Cell Therapeutics Ltd |
Método de qualificação de células, população isolada de células-tronco mesenquimais, método de tratamento de uma doença imune ou inflamatória, e uso de células-tronco mesenquimais
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
WO2015153339A2
(fr)
|
2014-04-01 |
2015-10-08 |
Monsanto Technology Llc |
Compositions et procédés pour lutter contre les insectes nuisibles
|
WO2015155777A1
(fr)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Compositions pour la réparation des os
|
EP3643795B1
(fr)
|
2014-04-14 |
2022-03-30 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé de détermination de mort de cellules ou de tissues par analyse de methylation de l'adn
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
EP3137502B1
(fr)
|
2014-04-27 |
2020-07-29 |
FameWave Ltd. |
Anticorps humanisés dirigés contre ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
US20170071208A1
(en)
|
2014-05-04 |
2017-03-16 |
Forrest Innovations Ltd. |
Compositions for mosquito control and uses of same
|
WO2015177800A2
(fr)
|
2014-05-22 |
2015-11-26 |
Yeda Research And Development Co. Ltd. |
Micro-organismes recombinés pouvant fixer le carbone
|
WO2015186129A1
(fr)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions et procédés d'inhibition sélective d'irp1 et traitement de l'inflammation
|
EP3149155B1
(fr)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
AU2015280252A1
(en)
|
2014-06-23 |
2017-01-12 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
EP3161480B1
(fr)
|
2014-06-25 |
2020-02-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Identification de cellules souches cancéreuses et utilisation de celles-ci pour des diagnostics et traitements
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
WO2015198326A1
(fr)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Formulations de liposome pour l'administration d'acides nucléiques
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
HUE049261T2
(hu)
|
2014-07-15 |
2020-09-28 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
CD44 izolált polipeptidek és alkalmazásaik
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
CN107076727B
(zh)
|
2014-07-21 |
2019-11-01 |
诺威尔卢斯德克有限公司 |
用于确定患者特定突变的致癌指数的方法和系统
|
RU2021123470A
(ru)
|
2014-07-29 |
2021-09-06 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с насекомыми-вредителями
|
EP3194572B1
(fr)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Milieux pour la culture de cellules souches pluripotentes
|
JP6661607B2
(ja)
|
2014-08-14 |
2020-03-11 |
メメド ダイアグノスティクス リミテッド |
多様体および超平面を用いる生物学的データのコンピュータ分析
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
AU2015313811A1
(en)
|
2014-09-08 |
2017-04-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
WO2016038609A1
(fr)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anticorps anti-her3 et leurs utilisations
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
WO2016042561A2
(fr)
|
2014-09-21 |
2016-03-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Freination du mir-132 pour le traitement de troubles lipidiques
|
DE102015220401B4
(de)
|
2014-10-20 |
2022-12-29 |
Gen-Probe Incorporated |
Erythrozyten-Lyselösung
|
WO2016075697A1
(fr)
|
2014-11-13 |
2016-05-19 |
Enzootic Holdings Ltd. |
Inversion de sexe fonctionnelle de femelles crustacés décapodes
|
CA2967233A1
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procede d'analyse de microbiome
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079739A2
(fr)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
|
JP6860483B2
(ja)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
細菌遺伝子の標的化削減
|
WO2016084084A1
(fr)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Construction d'acide nucléique pour l'édition de génome
|
WO2016092555A2
(fr)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
EP3240892B9
(fr)
|
2014-12-30 |
2020-07-22 |
Cell Cure Neurosciences Ltd. |
Populations de cellules de l'epr et leurs procédés de production
|
EP3240890B1
(fr)
|
2014-12-30 |
2021-06-16 |
Cell Cure Neurosciences Ltd. |
Évaluation de populations de cellules épithéliales pigmentaires rétiniennes
|
CA2972700A1
(fr)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Procedes de traitement de maladies retiniennes
|
IL253208B2
(en)
|
2015-01-04 |
2023-03-01 |
Protalix Ltd |
Converted DNase and its uses
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
WO2016118762A1
(fr)
|
2015-01-22 |
2016-07-28 |
Monsanto Technology Llc |
Compositions et méthodes de lutte contre leptinotarsa
|
WO2016135732A1
(fr)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Procédé favorisant la pousse des cheveux
|
US10781445B2
(en)
|
2015-03-11 |
2020-09-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
CA2981142A1
(fr)
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Therapie a base de lymphocytes t car diriges contre le recepteur lhr pour le traitement des tumeurs solides
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
US20180071369A1
(en)
|
2015-03-31 |
2018-03-15 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
CN114716390A
(zh)
|
2015-04-07 |
2022-07-08 |
Ela制药有限公司 |
用于治疗和/或预防细胞或组织坏死的组合物和方法
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
WO2016174674A1
(fr)
|
2015-04-27 |
2016-11-03 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Molécules de ciblage egr1 dans le traitement de maladies inflammatoires et hyperprolifératives
|
BR112017023448A2
(pt)
|
2015-04-29 |
2018-07-31 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
composições anti-fitopatogênicas
|
US20190031759A1
(en)
|
2015-04-30 |
2019-01-31 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
EA201792547A1
(ru)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Популяции бактерий для стимуляции состояния здоровья
|
EP3302571B1
(fr)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Variantes de l'oxyntomoduline pégylée
|
UY36703A
(es)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
Composiciones y métodos para la administración de un polinucleótido en una planta
|
WO2016196782A1
(fr)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
EP3302559B1
(fr)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Immunothérapie des cellules car ciblées par lym-1 et lym-2
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
EP3310388B1
(fr)
|
2015-06-18 |
2021-10-06 |
Yeda Research and Development Co., Ltd. |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
CN108289851B
(zh)
|
2015-06-19 |
2021-06-01 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
EP3322431A2
(fr)
|
2015-07-16 |
2018-05-23 |
Biokine Therapeutics Ltd. |
Compositions et méthodes pour le traitement du cancer
|
US11179448B2
(en)
|
2015-07-16 |
2021-11-23 |
Yeda Research And Development Co. Ltd. |
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
|
US10668094B2
(en)
|
2015-07-19 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
|
JP6976242B2
(ja)
|
2015-07-22 |
2021-12-08 |
フィトファーマ インターナショナル リミテッドPhytopharma International Ltd. |
ハナバチ摂取組成物、ハチミツの製造におけるその使用方法、およびそれにより製造されたハチミツ
|
EP3862425A1
(fr)
|
2015-07-29 |
2021-08-11 |
Hadasit Medical Research Services and Development Ltd. |
Production à grande échelle de cellules épithéliales pigmentaires rétiniennes
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
WO2017021961A1
(fr)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
DK3331994T3
(da)
|
2015-08-05 |
2022-11-21 |
Cell Cure Neurosciences Ltd |
Fremstilling af retinale pigmentepitelceller
|
CA2993910A1
(fr)
|
2015-08-05 |
2017-02-09 |
Cell Cure Neurosciences Ltd. |
Preparation de photorecepteurs pour le traitement de maladies retiniennes
|
WO2017025963A1
(fr)
|
2015-08-10 |
2017-02-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
EP3365376A1
(fr)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
WO2017072763A1
(fr)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Préparation de cellules de l'épithélium pigmentaire rétinien
|
EP3368024B1
(fr)
|
2015-10-27 |
2023-09-20 |
Akos Biosciences, Inc. |
Compositions comprenant du cannabidiol et un des seconds agents thérapeutiques pour le traitement du cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
WO2017081689A1
(fr)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
|
US11679133B2
(en)
|
2015-11-30 |
2023-06-20 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
WO2017103930A1
(fr)
|
2015-12-16 |
2017-06-22 |
Ramot At Tel-Aviv University Ltd. |
Particules comprenant un omentum décellularisé
|
WO2017115367A1
(fr)
|
2015-12-28 |
2017-07-06 |
The National Institute for Biotechnology in the Negev Ltd. |
Composition et méthode pour le traitement de la sclérose latérale amyotrophique
|
WO2017118985A1
(fr)
|
2016-01-06 |
2017-07-13 |
Yeda Research And Development Co. Ltd. |
Compositions et méthodes pour le traitement d'affections malignes, autoimmunes et inflammatoires
|
WO2017122203A1
(fr)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
JP7019580B2
(ja)
|
2016-01-21 |
2022-02-15 |
ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション (エー.アール.オー.) (ボルカニ センター) |
単為結実植物およびその製造方法
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
US11261433B2
(en)
|
2016-01-31 |
2022-03-01 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
RU2762089C2
(ru)
|
2016-02-04 |
2021-12-15 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
ПЕПТИДЫ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ, НАРУШЕНИЙ ИЛИ СОСТОЯНИЙ, АССОЦИИРОВАННЫХ С МУТАНТНЫМ р53
|
WO2017138007A1
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Diagnostic basé sur le microbiome, prédiction et traitement de l'obésité de rechute
|
WO2017138008A2
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
|
JP2019508422A
(ja)
|
2016-02-16 |
2019-03-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
シアノバクテリアおよび植物の増殖を阻害するための非タンパク質性フェニルアラニン類似体
|
EP3420075A4
(fr)
|
2016-02-23 |
2019-10-16 |
Chaya Brodie |
Production de cellules souches cancéreuses et leur utilisation
|
WO2017149538A1
(fr)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps spécifiques du récepteur du poliovirus humain (pvr)
|
US20190085378A1
(en)
|
2016-03-03 |
2019-03-21 |
Memed Diagnostics Ltd. |
Analyzing rna for diagnosing infection type
|
WO2017153982A1
(fr)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Procédé de modulation de la myélinisation
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
AU2017257978B2
(en)
|
2016-04-27 |
2022-12-22 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
WO2017203520A1
(fr)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(fr)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Nouvelles molécules destinées au traitement de l'inflammation
|
WO2017212494A1
(fr)
|
2016-06-09 |
2017-12-14 |
Opko Biologics Ltd. |
Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
|
EP3472342A1
(fr)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
|
JP7334043B2
(ja)
|
2016-06-27 |
2023-08-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
メモリーt細胞から作られるベト細胞
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
EP3482201B1
(fr)
|
2016-07-10 |
2022-12-14 |
Memed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
EP3481967A4
(fr)
|
2016-07-11 |
2020-04-22 |
Bonus Therapeutics Ltd. |
Compositions cellulaires pour la régénération tissulaire
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
KR102618424B1
(ko)
|
2016-07-11 |
2023-12-26 |
옵코 바이오로직스 리미티드 |
지속성 응고 인자 vii 및 그 제조 방법
|
CN109714962A
(zh)
|
2016-07-11 |
2019-05-03 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
用于在体外培养细胞的系统和方法
|
WO2018020489A1
(fr)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Méthodes et kits pour analyser des fragments de liaison à l'adn liés à l'adn
|
ES2965761T3
(es)
|
2016-08-08 |
2024-04-16 |
Tech Innovation Momentum Fund Israel Limited Partnership |
Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
|
EP3504553B1
(fr)
|
2016-08-10 |
2022-04-20 |
Memed Diagnostics Ltd. |
Système et procédé d'analyse de données biologiques
|
WO2018029693A1
(fr)
|
2016-08-10 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
AU2017311684B2
(en)
|
2016-08-14 |
2023-05-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal cell-derived exosomes to treat neurological disorders
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
WO2018047154A1
(fr)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
WO2018051347A1
(fr)
|
2016-09-14 |
2018-03-22 |
Yeda Research And Development Co. Ltd. |
Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
WO2018087759A1
(fr)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriestérases destinés au traitement ou à prévention des dommages associés à l'exposition aux organophosphates
|
JP2019535298A
(ja)
|
2016-11-28 |
2019-12-12 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
単離ポリヌクレオチドおよびポリペプチドおよび関心のある発現産物を発現させるためにそれらを使用する方法
|
US20190343782A1
(en)
|
2016-11-30 |
2019-11-14 |
Yeda Research And Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
MX2018016003A
(es)
|
2016-12-01 |
2019-05-16 |
Univ Ramot |
Tratamiento combinado para lesiones neurológicas.
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
BR112019019190A2
(pt)
|
2017-03-16 |
2020-04-22 |
Lineage Cell Therapeutics Inc |
métodos para o tratamento de doenças da retina
|
BR112019020953A2
(pt)
|
2017-04-05 |
2020-05-05 |
Yeda Res & Dev |
sistema de cultura ex-vivo e métodos de uso do mesmo
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
WO2018207184A2
(fr)
|
2017-05-10 |
2018-11-15 |
Ariel Scientific Innovations Ltd. |
Procédés de purification d'anticorps
|
US11714089B2
(en)
|
2017-05-21 |
2023-08-01 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
WO2018216011A1
(fr)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
EP3630973A1
(fr)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
WO2019012542A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
WO2019012544A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
WO2019012543A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
KR102510576B1
(ko)
|
2017-09-19 |
2023-03-14 |
트로픽 바이오사이언시즈 유케이 리미티드 |
유전자 발현을 침묵시키기 위한 식물의 비-암호화 rna 분자의 특이성 변형
|
WO2019094595A2
(fr)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Méthodes et compositions pour la génération et l'utilisation d'anticorps tau phosphorylés spécifiques à une conformation humanisée
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
WO2019106671A1
(fr)
|
2017-11-29 |
2019-06-06 |
Ramot At Tel-Aviv University Ltd. |
Procédés de traitement prophylactique ou thérapeutique de choc neurogénique
|
WO2019106667A1
(fr)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
|
WO2019106680A1
(fr)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie cardiaque ischémique
|
WO2019116376A1
(fr)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
WO2019130313A1
(fr)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155459A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs du protéasome 20s
|
EP3749368A1
(fr)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
WO2019162945A1
(fr)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
WO2019167047A1
(fr)
|
2018-02-28 |
2019-09-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Méthodes de diagnostic et de traitement du cancer de la vessie
|
EP3765034A1
(fr)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
WO2019186569A1
(fr)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
JP2021519283A
(ja)
|
2018-03-29 |
2021-08-10 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Pten阻害剤を含む小胞およびその使用
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
AU2019277908A1
(en)
|
2018-05-27 |
2021-01-07 |
Biolinerx Ltd. |
AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
WO2019234754A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Constructions d'acide nucléique et procédés d'utilisation de celles-ci
|
US20210337753A1
(en)
|
2018-06-07 |
2021-11-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of regenerating and transforming cannabis
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
EP3818529A2
(fr)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Évaluation spécifique à une personne de la sensibilité aux probiotiques
|
MX2021000263A
(es)
|
2018-07-11 |
2021-05-12 |
Kahr Medical Ltd |
Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma.
|
JP7395517B2
(ja)
|
2018-07-11 |
2023-12-11 |
イミュニティ ファルマ リミテッド |
ペプチド化合物およびその治療的用途
|
AU2019315054A1
(en)
|
2018-07-31 |
2021-03-18 |
Collplant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(fr)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
|
EP3852759A2
(fr)
|
2018-09-20 |
2021-07-28 |
Yeda Research and Development Co. Ltd |
Méthodes de traitement de la sclérose latérale amyotrophique
|
EP3856225A1
(fr)
|
2018-09-25 |
2021-08-04 |
BioLineRx Ltd. |
Procédés de sélection d'un traitement contre un cancer associé aux récepteurs cxcr4
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020152686A1
(fr)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Milieux de culture pour cellules souches pluripotentes
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3927378A1
(fr)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
EP3927807A1
(fr)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
EA202192430A1
(ru)
|
2019-03-05 |
2022-02-11 |
Те Стейт Оф Израэл, Министри Оф Эгрикалчер Энд Рурал Дивелопмент, Эгрикалчарал Рисёрч Органайзейшн (Аро) (Волкани Сентер) |
Птицы с отредактированным геномом
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
EP3946611A2
(fr)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Composés anti-viraux et anti-tumoraux
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
WO2020230133A1
(fr)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
AU2020279080A1
(en)
|
2019-05-22 |
2022-01-20 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
EP3976646A4
(fr)
|
2019-05-28 |
2023-04-19 |
Shanghaitech University |
Composition et méthodes pour le traitement d'une dysplasie ectodermique 2, type clouston
|
EP3983531A1
(fr)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Procédés de génération d'oligodendrocytes
|
EP3983540A1
(fr)
|
2019-06-16 |
2022-04-20 |
Yeda Research and Development Co. Ltd |
Méthode de stabilisation de l'arn intracellulaire
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
EP3994268A1
(fr)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
Alpha gliadine sans épitope et son utilisation pour la gestion de la maladie coeliaque et de la sensibilité au gluten
|
MX2022000367A
(es)
|
2019-07-11 |
2022-07-13 |
Kahr Medical Ltd |
Heterodimeros, metodos y uso de los mismos.
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021009740A1
(fr)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions et procédés pour le traitement de la tuberculose
|
WO2021019526A1
(fr)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement et de diagnostic du cancer du poumon
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(fr)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
WO2021038569A1
(fr)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Traitement de la vaginose bactérienne
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
EP4051695A1
(fr)
|
2019-10-31 |
2022-09-07 |
Yeda Research and Development Co., Ltd. |
Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
WO2021100034A1
(fr)
|
2019-11-19 |
2021-05-27 |
Protalix Ltd. |
Élimination de constructions à partir de cellules transformées
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
WO2021130753A1
(fr)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnostic de la démence frontotemporale
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137231A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
WO2021152587A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
CN115335532A
(zh)
|
2020-02-09 |
2022-11-11 |
Nlc制药有限公司 |
Sars-cov-2快速检测测试
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021173674A1
(fr)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
EP4121441A1
(fr)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
BR112022019510A2
(pt)
|
2020-03-29 |
2022-11-16 |
Yeda Res & Dev |
Variantes de beta-glucocerebrosidase para uso no tratamento de doença de gaucher
|
CN115484836A
(zh)
|
2020-03-31 |
2022-12-16 |
百欧穆斯有限公司 |
用于预防和治疗烟雾诱发的肺部损伤的细菌
|
EP4133107A1
(fr)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
WO2021205459A1
(fr)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(fr)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Procédés d'augmentation des taux de croisement de gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
EP4217370A2
(fr)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Méthodes et compositions pour traiter des infections à coronavirus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
KR20230104160A
(ko)
|
2020-10-07 |
2023-07-07 |
프로탈릭스 리미티드 |
장기-작용성 데옥시리보뉴클레아제(dnase)
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
US20230416750A1
(en)
|
2020-11-09 |
2023-12-28 |
1E Therapeutics Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
CA3200350A1
(fr)
|
2020-11-26 |
2022-06-02 |
Yanay OFRAN |
Sous-unite de glutenine modifiee a poids moleculaire eleve et ses utilisations
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
WO2022144883A2
(fr)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
Arnm de p21 ciblant des dnazymes
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
EP4294428A1
(fr)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Procédé de génération de vaccins
|
WO2022175951A1
(fr)
|
2021-02-18 |
2022-08-25 |
Yeda Research And Development Co. Ltd. |
Bactéries génétiquement modifiées pour générer des vaccins
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
AU2022247325A1
(en)
|
2021-03-30 |
2023-10-05 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
AU2022272135A1
(en)
|
2021-05-12 |
2024-01-04 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(fr)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Traitement combiné du cancer
|
EP4355857A1
(fr)
|
2021-06-13 |
2024-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé de reprogrammation de cellules humaines
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2022264076A1
(fr)
|
2021-06-16 |
2022-12-22 |
Seedx Technologies Inc. |
Procédés de tri de graines de matthiola
|
KR20240031315A
(ko)
|
2021-07-02 |
2024-03-07 |
트로픽 바이오사이언시즈 유케이 리미티드 |
바나나 과실의 갈변 지연 또는 예방
|
CA3226076A1
(fr)
|
2021-07-18 |
2023-01-26 |
Tracey Lodie |
Populations de cellules nk therapeutiques
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
WO2023012798A2
(fr)
|
2021-08-02 |
2023-02-09 |
Yeda Research And Development Co. Ltd. |
Anticorps pour le traitement du cancer
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
KR20240040770A
(ko)
|
2021-08-03 |
2024-03-28 |
제니시티 리미티드 |
조작된 tcr 복합체 및 이의 사용 방법
|
WO2023018621A1
(fr)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Cellules nk modifiées, leurs procédés de production et leurs utilisations
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023105526A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|